About This Study
The purpose of this study is to see how well a drug called selumetinib works for treating patients with neurofibromatosis type 1 associated low-grade glioma. Low-grade glioma is a type of cancer that affects the nervous system. We also want to see how well selumetinib works at improving vision in patients with low-grade glioma of the optic pathway. The optic pathway includes parts of the eye and brain that help us see.
Diagnosed with a genetic disorder called neurofibromatosis type 1 and a cancer called low-grade glioma. Study team will discuss study details with you.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 2 - 21 years old
- All Genders
Language
- This study enrolls English speakers only
Additional Study Information
- No compensation provided
- No reimbursement offered
Study Locations
- Greater Winston-Salem, NC